Source: NHS Choices
Area: News
NHS Choices has conducted an assessment of press reports, including one in the Daily Express that “the UK could face a ‘bindness epidemic’ caused by progressive eye conditions that is being grossly underestimated by the …
Day: February 16, 2012
Ranibizumab for diabetic macular oedema: results from 2 RCTs (RISE and RIDE)
Source: Ophthalmology
Area: News
The efficacy and safety of intravitreal ranibizumab in diabetic macular oedema (DMO) has been evaluated in two parallel, methodologically identical, phase III, studies (RISE and RIDE).
The studies involved …
Femtosecond Laser Increases Astigmatic Keratotomy Accuracy
Femtosecond laser makes astigmatic keratotomy more accurate and offers surgeons greater flexibility. Medscape Medical News
Vitreous Cause Most Retinal Disease
The vitreous is the culprit in just about every surgical retinal disease. A PVD is sometimes dangerous, but may prevent many retinal diseases.
WSU’s novel gene-therapy for blindness receives $250,000 FFB grant
Technology to restore vision through the use of a component of green algae – developed by a Wayne State University professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute – has attracted additional funding f…
Intraocular Ranibizumab No Quick Fix for Macular Edema
Up to two years of intraocular ranibizumab injections (Lucentis, Genetech) are safe in patients with retinal vein occlusion, researchers say. Reuters Health Information